Description

Tamodal 100 mg contains Temozolomide, an oral alkylating agent widely used in neuro-oncology. It is a standard component of treatment protocols for malignant brain tumors, often administered alongside radiotherapy or as maintenance therapy.

🔬 Mechanism of Action

Temozolomide is converted in the body to its active metabolite (MTIC), which methylates DNA at specific sites. As a result, it interferes with DNA replication and triggers cancer cell death. Therefore, it effectively targets rapidly dividing tumor cells in the brain.

💊 Indications

Tamodal 100 mg is indicated for:

• Newly diagnosed Glioblastoma Multiforme (GBM) (in combination with radiotherapy, followed by maintenance therapy)
• Recurrent or refractory Anaplastic Astrocytoma
• Other malignant gliomas as prescribed by an oncologist

📌 Key Features of Tamodal 100 mg

• Strength: 100 mg
• Dosage Form: Oral capsule
• Therapeutic Class: Alkylating Agent
• Administration: Taken orally, dosing based on body surface area and treatment phase
• Monitoring: Requires regular complete blood count (CBC) and liver function tests

⚕️ Benefits of Temozolomide

• Oral chemotherapy for convenience
• Standard-of-care therapy in GBM treatment
• Effective in both concurrent and maintenance settings
• Crosses the blood-brain barrier for targeted action

⚠️ Precautions

• Risk of myelosuppression (neutropenia, thrombocytopenia)
• Nausea, vomiting, fatigue, and constipation may occur
• Risk of opportunistic infections in prolonged therapy
• Regular blood monitoring required
• Use strictly under oncologist supervision

Tamodal 100 mg (Temozolomide Capsules) is a key oral chemotherapy agent in the management of malignant brain tumors, offering effective disease control and improved survival outcomes when used as part of comprehensive neuro-oncology treatment protocols.